Dormant stock getting ready for a comeback? "As we review the psychedelic market, it is clear that L-130 is a differentiated compound with a very unique profile not seen in any other product. We will pursue every avenue to ensure our share value is reflective of the potential of our science."
Liking the bullish stance the CEO is taking.